Differential effects of EGFL6 on tumor versus wound angiogenesis

Angiogenesis inhibitors are important for cancer therapy, but clinically approved anti-angiogenic agents have shown only modest efficacy and can compromise wound healing. This necessitates development of novel anti-angiogenesis therapies. Here, we show significantly increased EGFL6 expression in tum...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cell Rep
Main Authors: Noh, Kyunghee, Mangala, Lingegowda S., Han, Hee-Dong, Zhang, Ningyan, Pradeep, Sunila, Wu, Sherry Y., Ma, Shaolin, Mora, Edna, Rupaimoole, Rajesha, Jiang, Dahai, Wen, Yunfei, Shahzad, Mian MK, Lyons, Yasmin, Cho, MinSoon, Hu, Wei, Nagaraja, Archana S., Haemmerle, Monika, Mak, Celia SL, Chen, Xiuhui, Gharpure, Kshipra M., Deng, Hui, Xiong, Wei, Kingsley, Charles V, Liu, Jinsong, Jennings, Nicholas, Birrer, Michael J., Bouchard, Richard R., Lopez-Berestein, Gabriel, An, Zhiqiang, Sood, Anil K.
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5749980/
https://ncbi.nlm.nih.gov/pubmed/29212026
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.celrep.2017.11.020
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados